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Head and neck cancer
Salivary gland scintigraphy
Chemoradiotherapya b s t r a c t
Background and purposes: Permanent xerostomia as a result of radiation-induced salivary gland damage
remains a common side effect of radiotherapy (RT) of the head and neck. The purpose of this study was to
evaluate the usefulness of diffusion-weighted magnetic resonance imaging (DW-MRI) in assessing the
post-RT salivary gland function in patients with head and neck cancer (HNC).
Materials and methods: In this prospective study, 20 HNC patients scheduled for bilateral neck chemora-
diotherapy (CRT) with weekly cisplatin went through diffusion-weighted magnetic resonance imaging
(DW-MRI) and salivary gland scintigraphy (SGS) prior to and at a mean of six months after completing
the treatment. The changes in apparent diffusion coefficient (ADC) before and after treatment were com-
pared with ejection fraction (EF) measured with SGS and the radiation dose absorbed by the salivary
glands.
Results: As a result of gustatory stimulation with ascorbic acid, the ADC showed a biphasic response with
an initial increase and subsequent decrease. This pattern was seen both before and after RT. Post-RT ADC
increased as a function of RT dose absorbed by the salivary glands. A moderate statistical correlation
between pre- and post-RT ADCs at rest and EF measured with SGS was found.
Conclusions: DW-MRI seems a promising tool for detection of physiological and functional changes in
major salivary glands after RT.
 2016 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 122 (2017) 178–184Radiation-induced salivary gland damage and consequential
xerostomia is one of the most common and distressing adverse
effects of radiotherapy (RT) for head and neck cancer (HNC)
[1–2]. Mechanisms of salivary gland damage related to radiation
are incompletely understood [3] and interventions for reducing
radiation-induced hyposalivation remain limited. Despite the
modern highly conformal intensity modulated radiotherapy or
proton therapy (IMRT/IMPT) techniques, sparing of the salivary
gland function after RT is not always possible [4–5].
Thus far, salivary gland scintigraphy (SGS) and quantitative
salivary flow rate measurements have been the mainstay of
assessing the salivary gland function in HNC patients. SGS has
shown to be feasible of predicting post-RT salivary gland function
[6] but the usefulness of this measurement modality is limited byits invasiveness aswell as the radiation exposure related to it. Quan-
titative salivary flow rate measurements are somewhat unspecific
and their results are not always comparable between studies [7].
During the past years, diffusion-weighted magnetic resonance
imaging (DW-MRI) has gained increasing interest in assessing var-
ious conditions affecting salivary glands [8–16]. As an imaging
technique able to show the random thermal molecular diffusion
of water molecules (i.e. the Brownian motion) in biological tissues,
it characterizes tissues and generates image contrasts based on
differences in water mobility. The diffusion leads to signal attenu-
ation, which can be quantified as the apparent diffusion coefficient
(ADC). In highly cellular tissues, e.g. tumours, the movement of free
water is limited, which leads to decrease in ADC. On the contrary,
in hypocellular tissues, e.g. necrosis, the diffusion is high, which
can be detected as an increase in ADC [17–18].
DW-MRI’s feasibility of assessing salivary gland function has
been studied in healthy volunteers [19–21] and in patients with
various conditions affecting salivary gland function [10–11] as well
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studies have shown that changes in ADC both before and after gus-
tatory stimulation correlate with changes in salivary gland func-
tion. Still, in these studies the alterations in ADC before and after
RT and responses to salivary stimulation have varied widely, and
their clinical relevance remains incompletely understood. Further
interpretation is needed to achieve a better understanding of the
usability of DW-MRI in this area.
In this prospective study of 20 patients treated with IMRT for
head and neck cancer we aimed at evaluating the feasibility of
DW-MRI for assessing the post-RT salivary gland function both at
rest and in a stimulated state by matching alterations in ADC to
radiation dose absorbed by the salivary glands and comparing
the results with SGS.Patients and methods
This prospective study comprises 21 consecutive patients with
histologically confirmed squamous cell carcinoma of the head
and neck region who were scheduled for bilateral neck IMRT with
a curative intent between May 2012 and July 2013. One patient
dropped out of the study due to numerous treatment-related com-
plications, resulting in a total of 20 patients included in the analy-
ses. An institutional Research Ethics Board approval was granted
for the study, and informed consent was obtained from all patients
prior to participation.
The main patient and tumour characteristics are presented in
Table 1.
Prior to treatment, the patients went through standard pre-
treatment evaluation including clinical head and neck examina-
tion, imaging (CT/MRI) and endoscopy. All diagnoses were
histopathologically confirmed. The tumours were staged according
to the 7th UICC TNM classification. All patients had a good perfor-
mance status (ECOG 0-1) and none of them had any previous sali-
vary gland diseases or other medical causes of xerostomia.Treatment
All patients received IMRT-based chemoradiotherapy (CRT)
with weekly cisplatin 40 mg/m2. A thermoplastic head and neck
mask (Orfit) was used for immobilization of the patients.
Treatment target delineation was based on treatment planning
CT and MRI, both performed in the treatment position.
Irradiation was performed with a 6 MV linear accelerator using
a dynamic multileaf collimator with the sliding window principle.
In all patients the treatment was given with 2 Gy daily fractions up
to the planned dose with a mean treatment duration of 49 days
(range, 46–56 days). All patients first received 50 Gy to the elective
lymph node areas on both sides of the neck as well as to the
macroscopic tumour area(s). Thereafter the RT volume wasTable 1
Patient and tumour characteristics.
Male/female, n (%) 16 (80%)/4 (20%)
Age, years (mean) 42–74 (59.5)









IVc 0 (0%)reduced (once in 11 patients and twice in 9 patients) and the high
risk/macroscopic tumour areas were boosted up to 60–70 Gy. In 19
of the patients the CRT was given as a definitive treatment with the
total prescribed dose up to 70 Gy; the remaining patient went
through neck dissection due to recurrent lymph node metastases
of a previously operated carcinoma of the soft palatine whereafter
she received postoperative CRT up to 60 Gy.
The mean RT dose to the contralateral parotid gland was aimed
at being kept <26 Gy whenever feasible. Also the dosage to sub-
mandibular glands was tried to be kept as low as reasonably
possible.MRI protocol
The imaging was performed with a 1.5 T MR scanner GE
Optima MR450w (GE Medical Systems, Milwaukee, WI, USA).
MRI scans were made a mean of 8 days (5–15) prior to the treat-
ment onset and a mean of 6 months (with an exception of one
patient who underwent imaging already at 3.7 months) after com-
pletion of the treatment.
Prior to treatment the routinely used fast recovery fast spin
echo T2-weighted (TE = 89 ms, TR = 9400 ms, matrix size =
416  224, slice thickness = 3.5 mm, gap = 1.0 mm, FOV = 260 mm)
and contrast-enhanced T1-weighted (TE = 3 ms, TR = 17 ms, matrix
size = 256  256, slice thickness = 2.0 mm, gap = 0, FOV = 280 mm)
RT planning images with six channel Neuro Flex coils were first
obtained with the patient wearing an immobilization mask. Then
the patients were repositioned to a 32-channel head-neck-spine
(HNS) coil and their heads were supported with vendor’s cushions.
For the purposes of this study, T2-weighted imaging with same
parameters as above and DW echo-planar imaging (EPI) were per-
formed. In the post-RT scans, only T2 and DWI sequences with the
32-channel HNS coil were included.
Twenty-nine transverse DWI images (TE = 76 ms, TR = 5700 ms,
matrix size = 128  128, gap = 0 mm, FOV = 260 mm) were
obtained with b factors of 0 and 700 s/mm2 – the latter value
was chosen because it was high enough to exclude the contribu-
tion from tissue perfusion but low enough to retain high signal
intensity level [22]. The slice thickness varied between 3.5–
3.9 mm depending on the patient size and was the same in pre-
and post-RT imaging. Entire parotid and submandibular glands
were included in each of the scans. The constant acquisition time
of each DWI sequence was 90 s including the prescanning time
of 39 s and without delay the scanning time of 51 s. The first two
DWI series were acquired at rest, whereafter the patients were
given two 500 mg tablets of ascorbic acid orally. For salivary stim-
ulation, the patients were advised to bite the tablets. Then, the
DWI sequence was repeated a mean of ten times.
ADC maps were saved in the AW workstation (version 4.6, GE
Medical Systems, Milwaukee, WI, USA) using READY View
software, and EPI correction was applied to remove EPI
distortions. The ADCs were calculated from the equation:
S(i) = S0  exp(bi  ADC) where S(i) is the signal intensity mea-
sured on the ith b value image, bi is the corresponding b value,
and S0 is the exact signal intensity for b = 0 s/mm2. For DWI analy-
sis, the data were transferred from the AW workstation to the
image processing software (MIM 5.6, MIM Software Inc., Cleveland,
OH, USA). The ADC was measured on ADC maps using regions of
interest (ROIs) placed over each of the salivary glands. For this pur-
pose, all of the salivary glands were manually delineated on DWI
sequences, and for anatomical reference also on T2-weighted
images. Large vessels, such as the retromandibular vein and the
external carotid artery were excluded. DWI scans of each patient
were manually registered to each time series to minimize the
interpretation bias caused by the geometric distortion in EPI DWI
images.
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All patients underwent salivary scintigraphy at a mean of 3 days
prior to the treatment onset (range, 11 days prior to – 5 days after)
and a mean of 6 months after completing the treatment (one
patient underwent SGS already at 3.5 months after the treatment).
Dynamic 99mTc pertechnetate (185 MBq) imaging was performed
using Siemens Symbia T2 gamma camera, and a lemon juice bolus
was used to stimulate saliva excretion after 15 min of imaging. The
imaging procedure is described elsewhere [6]. For the calculation
of salivary ejection fraction (sEF) the four major salivary glands
were segmented in the dynamic image series, resulting in four
time-activity curves. An additional ROI was contoured for back-
ground correction. The sEF was calculated using equation
sEF ¼ Cmax  Cmin
Cmax  Cbg
where Cmax and Cmin are the detected counts in the salivary gland
ROI immediately before and after the stimulus, respectively, and
Cbg are the counts in the background ROI. The relative ejection frac-
tion (rEF) was calculated from rEF(t) = sEF(t)/sEF(0), where sEF(t)
was defined six months after RT and sEF(0) was the baseline value
measured before RT.Statistical analysis
SPSS Statistics software was used for the statistical analyses.
The normality of the data was confirmed using Kolmogorov–Smir-
nov and Shapiro–Wilk-tests. T-test andWilcoxon Signed Ranks test
were used to compare different ADC values. P-values of <0.05 were
considered statistically significant.
The data in the graphs were divided into subgroups of equal
sizes to demonstrate dependence pattern between the compared
parameters. Pearson correlation coefficient was calculated to
investigate the dependence between dose, ADC and scintigraphy
parameters.Results
High-quality MRI scans were obtained for all patients. In all
patients, both of the parotid glands appeared normal in the T1
and T2 sequences, resulting in a total of 40 examined parotid
glands. On the contrary, one patient had only one submandibular
gland and one patient was lacking both of them, resulting in 37
examined submandibular glands.
The mean total RT doses to the right and left parotid glands
were 30.2 Gy (range, 19.5–47.7 Gy) and 37.4 Gy (21.7–55.9 Gy),
respectively. The corresponding doses to the right and left sub-
mandibular glands were 46.3 Gy (27.0–68.1 Gy) and 59.6 Gy
(36.7–70.4 Gy).
Baseline ADC (103 mm2/s, mean ± SD) at rest (i.e. in pre-
stimulated glands) was higher in submandibular glands
(1.35 ± 0.09) than in parotid glands (1.15 ± 0.12) (p < 0.001). The
corresponding post-RT values for submandibular and parotid
glands in an unstimulated state were 1.73 ± 0.22 and 1.48 ± 0.16
respectively (Table 2). This increase in ADC values after RT was sta-
tistically significant (p < 0.001) for both parotid and submandibular
glands.
After salivary stimulation with ascorbic acid, an initial increase
and subsequent decrease in ADC was seen in both parotid and sub-
mandibular glands. This pattern of response to salivary stimulation
was present both pre and post RT. The maximum ADC value after
stimulation (ADCmax) was significantly higher in irradiated glands
(post-RT) compared with the non-irradiated ones (pre-RT)
(p < 0.001). Also the change from baseline to the ADCmax wassignificantly higher in the post-RT setting compared with the
pre-RT one (p < 0.01) (Table 2).
We also found a linear correlation between the RT dose
absorbed by the salivary glands and pre- and post-RT changes in
ADC (ADCpost–pre) (Fig. 1). This dose–response relationship was
seen in both parotid and submandibular glands in the pre-
stimulated state (p < 0.001) as well as in the first ADC registration
point after salivary stimulation.
Fig. 2 depicts the pre- and post-RT ADC histograms of a single
patient’s salivary glands at rest. Here, considering each of the sali-
vary glands separately, it is seen that the ADC values inside the
salivary glands are normally distributed, and that in the glands that
absorbed a high RT dose, the ADC distribution after RT is shifted to
right whereas no noticeable change is seen in the glands that
received a low RT dose.Scintigraphy
Salivary scintigraphy was performed for all patients before and
after treatment. Three parotid and 9 submandibular glands showed
no measurable pretreatment function, and one post treatment
measurement failed because the patient’s head was moving during
the measurement. The glands whose activity was failed to be mea-
sured were excluded from the analysis. This resulted in a total of
35 examined parotid glands and 30 examined submandibular
glands.
Relative ejection fraction (rEF), defined as the ratio of the sali-
vary ejection fraction after and before treatment, decreased as a
function of the mean RT dose absorbed by the salivary glands; this
was in accordance with our previously reported results [6].
The relationship between pre- and post-RT changes in baseline
ADCs and rEFs is presented in Fig. 3. When matching prestimulated
ADCpost-pre values and rEFs for all of the examined salivary glands
(n = 65), a modest correlation (r = 0.38, p < 0.01) was found.
When regarding the parotid and submandibular glands separately,
the corresponding correlations were r = 0.29, p < 0.1 and
r = 0.50, p < 0.01, respectively.
The temporal relationship between SGS and DWI measure-
ments is schematically presented in Fig. 4 (Suppl data). Here, it is
visualized that the peak salivary gland technetium intake right
before the activity drop in SGS corresponds to the baseline ADC
in DW-MRI. The time gap between the moment when the patient
bites the ascorbic acid tablets and when post-stimulation DWI
measurements are started to be made is estimated to be about
25 s. Thus, the post-stimulation DWI series correspond to the time
after the activity drop in SGS has already happened. DW and SGS
images on an example patient before RT are presented in Fig. 5
(Suppl data).Discussion
In this prospective study we characterized the pre- and post-RT
distribution of ADC values in salivary glands at rest and in a stim-
ulated state. These results were compared with SGS. Our main
findings were the increase of ADCpost-pre values as a function of
the RT dose absorbed by the salivary glands in both prestimulated
and stimulated states and the moderate statistical correlation
between prestimulated ADCpost-pre values and rEFs measured by
SGS. In this study we also confirmed some of the previously
reported data about the DW-MRI and SGS.
In previously published articles [10–11,14–15,19–20] of
patients and healthy volunteers, the pattern of response to
gustatory stimulation in DW-MRI and changes in the ADC as a
result of RT to the salivary glands have varied considerably. The
correlation between changes in ADC and clinical parameters, such
Table 2
Summary of the measurement characteristics.
Mean ± 1SD PG, right PG, left PG, both SMG, right SMG, left SMG, both
Dmean, Gy 30.2 ± 8.8 37.4 ± 10.6 33.8 ± 10.3 46.3 ± 14.2 59.6 ± 12.3 52.7 ± 14.7
EFpre, % 44.4 ± 17.1 43.5 ± 16.0 44.0 ± 16.3 35.4 ± 13.9 29.8 ± 16.6 32.7 ± 15.3
EFpost, % 29.1 ± 18.6 26.9 ± 20.3 28.0 ± 19.3 16.1 ± 14.2 4.9 ± 7.9 10.7 ± 12.8
rEF, % 64.0 ± 37.1 56.9 ± 46.0 60.5 ± 41.2 52.3 ± 43.6 22.6 ± 31.5 37.9 ± 40.5
ADCbase, pre, (103) 1.15 ± 0.11 1.14 ± 0.13 1.15 ± 0.12 1.34 ± 0.09 1.37 ± 0.10 1.35 ± 0.09
ADCstim1, pre, (103) 1.38 ± 0.16 1.38 ± 0.23 1.38 ± 0.20 1.70 ± 0.22 1.68 ± 0.27 1.69 ± 0.24
ADCmax, pre, (103) 1.43 ± 0.14 1.42 ± 0.21 1.42 ± 0.18 1.79 ± 0.18 1.80 ± 0.25 1.79 ± 0.21
Tmax, pre, s 158 ± 82 144 ± 79 151 ± 80 156 ± 73 155 ± 92 156 ± 81
ADCbase, post, (103) 1.44 ± 0.17 1.52 ± 0.15 1.48 ± 0.16 1.66 ± 0.21 1.81 ± 0.20 1.73 ± 0.22
ADCstim1, post, (103) 1.69 ± 0.23 1.81 ± 0.25 1.75 ± 0.24 2.00 ± 0.30 2.28 ± 0.34 2.14 ± 0.35
ADCmax, post, (103) 1.76 ± 0.20 1.87 ± 0.28 1.82 ± 0.25 2.21 ± 0.22 2.49 ± 0.42 2.35 ± 0.36
Tmax, post, s 198 ± 126 185 ± 126 191 ± 124 223 ± 142 235 ± 139 229 ± 138
PG = parotid gland, SMG = submandibular gland, Dmean = mean absorbed dose, EFpre = ejection fraction before RT, EFpost = ejection fraction 6 months after RT, rEF = EFpost/EFpre,
ADCbase, pre/ADCbase,post = baseline ADC before/after RT, ADCstim1, pre/ADCstim1, post = ADC in the first measurement point after gustatory stimulation before/after
RT, ADCmax, pre/ADCmax, post = maximum ADC value after gustatory stimulation before/after RT, Tmax, pre/Tmax, post = Time to ADCmax before/after RT.
V. Loimu et al. / Radiotherapy and Oncology 122 (2017) 178–184 181as subjective xerostomia and absolute salivary flow rates remains
unclear. Further, the relationship between RT dose to the salivary
glands and changes in ADC or the correlation between pre and post
RT changes in ADC and rEFs have not previously been proven.
In this series, the baseline ADC at rest was significantly higher
in submandibular than in parotid glands. This finding is in accor-
dance with previous studies [15,19] and it is thought to reflect
the higher proportional amount of extracellular water of the sub-
mandibular glands [15]. Also most of the previously published
studies reported the post-RT rise in ADC values of prestimulated
glands using high b values [12–15]. This rise is thought to reflect
the increased water diffusivity in the damaged salivary glands as
a result of cellular loss, fibrosis or both [15].
In the present study, the gustatory stimulation with two
500 mg tablets of ascorbic acid resulted in a significant rise in
ADC values of unirradiated glands. According to the previous
reports, the pattern of response to gustatory stimulation in non-
irradiated glands has varied widely. This may contribute to the
b-values chosen (lower b values are more sensitive to perfusion
whereas higher b values detect the actual diffusion, [22–23]) and
– perhaps more importantly – the used stimulating agent. In their
studies Thoeny [19] and Dirix [15] used a 500 mg tablet of ascorbic
acid as the stimulating agent and advised the patients to let the
tablet dissolve in their mouths, not to chew on it. This resulted
in an initial decrease and subsequent increase in the ADC values.
Meanwhile, Habermann [20], Ries [10], Kato [11] – having used
lemon juice as a stimulant – and Zhang [14] – who performed
the gustatory stimulation with six tablets of 100 mg of ascorbic
acid – reported an initial increase and subsequent fluctuation in
the ADC values. This pattern of response to gustatory stimulation
was also seen in our study. This may be explained by the quicker
saliva production as a response to more immediate stimulation
[14]: lemon juice, higher number of tablets of ascorbic acid or
two instantly bitten tablets of ascorbic acid are likely to stimulate
simultaneously more receptors than a single slowly dissolving
tablet of ascorbic acid does.
When regarding the post-RT state, this pattern of response to
gustatory stimulation still existed in our patients, suggesting a per-
sisting capacity of the acinar cells to produce saliva upon stimula-
tion [14]. Also the range of increase of the ADC values was higher in
irradiated glands compared with the non-irradiated ones, suggest-
ing a greater increase of free water in the extracellular space. As
Zhang et al. [14] suggested, this may be due to delayed saliva emp-
tying due to damaged salivary duct system after RT. A similar post-
RT response to gustatory stimulation was reported by Zhang et al.
in 28 patients with nasopharyngeal carcinoma at 2 weeks after fin-
ishing the treatment [16]. On the contrary, in their series of 8patients with HNC, Dirix et al. reported a loss of the pre-RT pattern
of response to gustatory stimulation in non-functional glands at
9 months after finishing the RT [15]. This difference may partly
be attributable to the different kind of salivary stimulation.
The relationship between the RT dose to the salivary glands and
changes in ADC in the unstimulated state has previously been
investigated by Doornaert [12] and Marzi [13]. In their series of
34 patients, Marzi et al. found a correlation between the RT dose
to the parotid glands and pure diffusion coefficient (r = 0.197,
p = 0.046) and parotid shrinkage (p = 0.010) when data from mea-
surement points at half way through and at the end of RT were
taken into account. No significant correlation between ADC
changes and parotid RT dose was reported. Meanwhile, in their
small study of 8 patients with HNC, Doornaert et al. found a better
correlation between RT dose absorbed by the salivary glands and
changes of ADC at certain ROIs of the salivary glands when using
HASTE technique (r = 0.33) than when using the EPI technique
(r = 0.11) at 2–3 months after finishing the RT. Still, to our knowl-
edge, our study was the first one to confirm a dose–response rela-
tionship in ADC changes in a longer term follow up. The increase in
ADC as a result of RT damage was evident in irradiated salivary
glands – the more clearly the higher the RT dose was. This depen-
dency was more clearly evident in submandibular glands com-
pared with the parotid glands, probably due to the higher RT
dose absorbed by submandibular glands. Further, the dose–re-
sponse correlation was also present in the stimulated state – even
though weaker than in the pre-stimulated state. This weaker
correlation in stimulated salivary glands may partly be due to
uncertainties related to salivary gland stimulation procedure.
Finally, we analysed the correlation between ADCpost–pre and
rEF. This correlation was more evident in submandibular glands
(r = -0.50, p < 0.01) compared with parotid glands (r = 0.29,
p < 0.1). The stronger correlation coefficient in submandibular
glands may partly be explained by higher RT dose absorbed by
these glands. Correlating these two modalities with each other is
difficult, as SGS and DW-MRI do not measure exactly the same
things. While DW-MRI depicts the movement of water molecules
in the salivary gland tissue and does not directly reflect the secre-
tory function, the Tc99 m pertechnetate uptake in SGS reflects the
parenchymal function and the output reflects the secretory
function (Fig. 4). However, this correlation suggests that there is
a clinical relevance in changes in ADC in terms of decreased
salivary gland output. In this study, no absolute of subjective
xerostomia was assessed. However, in our previous studies [6,30]
we have shown a clear correlation between absolute salivary flow
rates ad EF measured with SGS, which further confirms the clinical
relevance of this finding.

































Parotid glands 6 months after RT
n = 40
r = 0.48; p < 0.01






























Parotid glands 6 months after RT
n = 40
r = 0.61; p < 0.001





























Submandibular glands 6 months after RT
n = 37
r = 0.64; p < 0.001






























Submandibular glands 6 months after RT
n = 37
r = 0.53; p < 0.001
Fig. 1. The change of ADC values (ADCpost–pre) in pre- and post-stimulated states as
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ADC (x 10-3 mm2/s)
Submandibular gland, le (mean 70 Gy)
PRE RT
POST RT
Fig. 2. A single-patient example of ADC histograms of pre-stimulated salivary
glands before and at six months after RT.
182 DW-MRI and salivary gland function in HNC patientsThere are some limitations that should be pointed out: First, the
number of patients was relatively small which may make the
statistics difficult to interpret. Second, imaging technique and
equipment may contribute to the results. Not all of the salivary
glands could be analysed with SGS due to inability to measure theirfunction. The time gap between the patient biting the tablet of
ascorbic acid and the initiation of DW imaging varied between 5
and 50 s. This delay may have caused some inaccuracies in measur-
ing of the ADC values in the stimulated state. Further, only one b
factor in addition to zero could be used in this study. It was chosen
to be 700 to allow decently high resolution while excluding the
perfusion component. Use of more than two b values would possi-
bly have led to different changes in ADC. In addition, EPI scans,
especially with high b-values, are prone to notable geometric dis-
tortions. To minimize the uncertainty caused by this distortion, we
registered each time series manually to the scans. Finally, earlier
publications [3,24] have reported on regional differences in














Parotid+SM glands 6 months after RT
n = 65
r = -0.38; p < 0.01
Fig. 3. The relationship between relative ejection fraction (rEF) and change of
baseline ADC values in all salivary glands.
V. Loimu et al. / Radiotherapy and Oncology 122 (2017) 178–184 183radiosensitivity inside the salivary glands. According to them, it is
suggested that acinic cell progenitors are located exclusively
within the parotid ducts, particularly the larger ones, and that irra-
diating these regions to high doses is very likely to cause irre-
versible xerostomia due to RT-induced stem cell loss and
consequential inability of the salivary glands to regenerate. Since
the present study was performed primarily to compare DW-MRI
with SGS, and since the regional resolution in planar SGS scans is
poor, no specific dose distribution inside the salivary glands and
its correlations to measurement parameters could be analysed.
Over the past decade, the role of diffusion weighted MR imaging
in patients with HNC has gained increasing interest. In addition to
the increasing understanding of its capability to depict physiolog-
ical and functional changes in salivary glands after RT, it has also
proven to be a promising tool for tissue characterization, nodal
staging and early response evaluation in this patient group
[25–29].
Until recently, evaluation of the salivary gland function in this
patient group has been based on SGS. However, the use of this
measurement modality is limited by the radiation exposure related
to it as well as lack of resolution in planar images to allow regional
assessment of the salivary gland function. With DW-MRI, better
information on regional changes inside the salivary glands could
be achieved without additional radiation exposure. As the DWI
scans take only a few minutes to obtain in addition to the routinely
used planning-MRI sequences, this is also much more convenient
to the patients. Since our aim would be to use more adaptive treat-
ment strategies for these patients in the future, adding DW
sequences routinely to planning-MR scans could give more
detailed information not only on anatomical structures and early
tumour response but also on salivary gland function, thus allowing
the possibility to adjust the treatment plan accordingly.
Conclusions
Our results showed that Post-RT changes in ADC correlate with
RT dose absorbed by the salivary glands and rEF measured by SGS,
suggesting that DW-MRI could be a useful tool for detection of
radiation-induced physiological and functional changes in the
major salivary glands in HNC patients. More investigation is
needed to fully understand the optimal way of using DW imaging
in the assessment of salivary gland function in this patient group.
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